Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
This report evaluates the benefits of marketing to seniors for the pharmaceutical industry. Globally, the number of older people will increase from 606m in 2000 to 1.9bn in 2050 and as a result healthcare needs will increase and drugs will be used for longer.
This report analyzes commercial opportunities within the gray market and shows how companies can meet these needs and keep company profits high. Current and future growth prospects are examined for pharmaceutical companies to 2008 in seven major indications particularly associated with seniors. These are
- Acute ischemic stroke
- Alzheimer's disease
- Arthritis
- Diabetes
- Male sexual dysfunction
- Osteoporosis
- Prostate cancer.
Cumulatively, the total value of these markets was approximately $42bn in 2002 and this figure is set to rise dramatically.
Table of Contents
Download Table of Contents as a PDF
Other users found this report page using the following search terms: aging ageing
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.